And studies have confirmed that VEGF can be used as an independent prognostic factor for esophageal cancer, which is closely related to tumor burden, lymph node metastasis, and recurrence [28]. This evidence concerns the gene VEGFA and metastatic malignant neoplasm in the lymph nodes.